Add like
Add dislike
Add to saved papers

The safety of EVAS surgical conversion in a comparative monocentric analysis.

OBJECTIVES: Endovascular aneurysm sealing (EVAS) was a widespread technology to treat abdominal aortic aneurysm (AAA). However, the particular morphology and structure of this Endoprosthesis predisposed to proximal sealing defects with a high rate of re-intervention or conversion to open surgery treatments. The purpose of this article is to report our experience on late open conversion of Nellix device, compared to previous reported experience.

MATERIALS AND METHODS: Between September 2013 and February 2020, 8 late open surgical conversions for endoleak were performed in our center: four of these were for EVAR. Four of these were EVAS devices required explantation and were included in the study. All excisions of infected abdominal aortic endo-graft were excluded.

RESULTS: All patients were treated within the original instructions for use (IFU). Aorto-bi-iliac reconstruction was performed with a bifurcated Dacron graft in all 4 cases. At 12 months Doppler ultrasonography (DUS) follow-up good results at short term with preserved primary patency and freedom of re-intervention in three cases were reported . Only one patient died 16 days after the procedure. Nevertheless the endo-prosthetic structure allows in three of our cases to clamp down the renal level, with a decrease of the time of lower limbs ischemia and greater safety of the open surgery repair procedure.

CONCLUSION: The EVAS conversion is common and a closer follow up is required. The most recurrent open surgery indication is the its migration and the Endoleak type 1. The procedure is influenced by multiple comorbidities; emergency graft excision appears to increase morbidity and mortality, compared to elective surgical setting.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app